ArticleBlood2021

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL.

Hanna Kirchhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.